Stephens Downgrades Catalyst Pharmaceutical Partners (CPRX) to Equal Weight
Stephens analyst Sudan Loganathan downgraded Catalyst Pharmaceutical Partners (NASDAQ: CPRX) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
